Pfizer’s Stock Is Down 44% YTD As Woes Continue
December 01, 2023 at 10:33 AM EST
Pfizer's shares plunged on Friday after the drugmaker halted the trial of its twice-daily obesity drug.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|
